DUBLIN (AP) — DUBLIN (AP) — Amarin Corp. PLC (AMRN) on Wednesday reported a loss of $25.1 million in its third quarter.
The Dublin-based company said it had a loss of 6 cents per share. Losses, adjusted for stock option expense, were 5 cents per share.
The biopharmaceutical company posted revenue of $42.3 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $43.8 million.
In the final minutes of trading on Wednesday, the company's shares hit 60 cents. A year ago, they were trading at 69 cents.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMRN at https://www.zacks.com/ap/AMRN
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.